| 04.06 07:25 | dpa-AFX: *JEFFERIES STARTET PACIFIC BIOSCIENCES MIT 'BUY' - ZIEL 4 USD |
| 04.06 07:25 | dpa-AFX: *JEFFERIES STARTS PACIFIC BIOSCIENCES WITH 'BUY' - PRICE TARGET 4 USD |
| 09.05 22:08 | dpa-AFX: Pacific Biosciences Of California, Inc. Q1 Loss Decreases, Beats Estimates |
| 09.05 22:07 | dpa-AFX: *PACBIO Q1 REVENUE $38.81 MLN VS. $38.90 MLN LAST YEAR |
| 09.05 22:07 | dpa-AFX: *PACBIO Q1 LOSS/SHARE $0.29 VS. LOSS $0.36 YEAR AGO |
| 09.05 22:07 | dpa-AFX: *PACBIO Q1 NET LOSS $78.18 MLN VS. LOSS $88.02 MLN PRIOR YEAR |
| 17.04 14:00 | dpa-AFX: Pre-market Movers: INVO, AILE, VNDA, CXAI, CHRO. |
| 16.04 15:05 | dpa-AFX: PacBio Q1 Prel. Revenue Nearly Flat, Annual Revenue Outlook Below View; Stock Down |
| 16.04 14:07 | dpa-AFX: *PACBIO Q1 PRELIM. REVENUE FLAT AT $38.8 MLN; NOW SEES 2024 REVENUE AT $170 MLN - $200 MLN |
| 15.02 22:10 | dpa-AFX: Pacific Biosciences of California, Inc. Q4 Earnings Summary |
| 15.02 22:09 | dpa-AFX: *PACBIO Q4 REVENUE $58.36 MLN VS. $27.35 MLN LAST YEAR |
| 15.02 22:09 | dpa-AFX: *PACBIO Q4 LOSS/SHARE $0.31 VS. LOSS $0.37 YEAR AGO |
| 15.02 22:09 | dpa-AFX: *PACBIO Q4 NET LOSS $82.02 MLN VS. LOSS $84.38 MLN PRIOR YEAR |
| 15.02 21:03 | dpa-AFX: Pacific Biosciences Of California Q4 23 Earnings Conference Call At 5:00 PM ET |
| 10.01 21:00 | dpa-AFX: Pacific Biosciences Of California To Present At J.P. Morgan Conference; Webcast At 4:30 PM ET |
| 09.01 16:44 | dpa-AFX: Pacific Biosciences Of California Climbs 7% |
| 08.01 14:50 | dpa-AFX: PacBio Prel. Q4 Revenue Surges, But Stock Down In Pre-market |
| 08.01 14:13 | dpa-AFX: *PACBIO EXPECTS Q4 PRELIMINARY PRELIMINARY CONSUMABLES REVENUE APPROX. $18.9 MLN |
| 08.01 14:13 | dpa-AFX: *PACBIO EXPECTS Q4 PRELIMINARY INSTRUMENT REVENUE OF APPROX. $35.1 MLN |
| 08.01 14:12 | dpa-AFX: *PACBIO FY PRELIMINARY REVENUE OF $200.5 MLN REPRESENTS Y-O-Y GROWTH OF 56% |
|
|
